• At its 2026 annual shareholder meeting, Q32 Bio’s shareholders ratified Ernst & Young as auditor for the year ending Dec. 31, 2026.
• Shareholders also elected Kathleen LaPorte, Jodie Morrison, and Arthur Tzianabos as Class II directors, with terms running to the 2029 annual meeting.
• A separate advisory vote endorsed the company’s named executive officer compensation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Q32 Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-272562), on June 16, 2026, and is solely responsible for the information contained therein.